Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the PEG ratio high or low?
The PEG ratio of 1.03 is 69% above its 2-year average of 0.61, near the high end of its 2-year range (0.22–1.03).
As of the fiscal period ended Tuesday, March 31, 2026. 27.95% above its 12-month average of 0.80.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
1.03
PEG RATIO AVG TTM
0.80
PEG RATIO AVG 3Y
0.61
PEG RATIO AVG 5Y
0.61
PEG RATIO AVG 10Y
1.67
PEG RATIO AVG 15Y
2.30
PEG RATIO AVG 20Y
0.59
CURRENT VS TTM AVG
+27.95%
CURRENT VS 3Y AVG
+68.85%
CURRENT VS 5Y AVG
+68.85%
CURRENT VS 10Y AVG
-38.20%
CURRENT VS 15Y AVG
-55.13%
CURRENT VS 20Y AVG
+73.69%
SECTOR MEDIAN · HEALTHCARE
1.82
median of 49 covered companies
CURRENT VS SECTOR MEDIAN
-43.41%
vs the sector median at left
Market Cap
$22.42B
PEG Ratio
1.16
TTM Avg
0.84
3Y Avg
0.59
5Y Avg
0.59
Market Cap
$25.07B
PEG Ratio
33.99
TTM Avg
33.99
3Y Avg
32.78
5Y Avg
16.88
Market Cap
$26.18B
PEG Ratio
1.43
TTM Avg
4.21
3Y Avg
4.21
5Y Avg
2.20
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| STERIS plc (STE) | $23.02B | 1.03 | 0.80 | 0.61 | 0.61 |
| BioNTech SE (BNTX)vs › | $23.50B | N/A | 0.23 | 0.12 | 0.12 |
| United Therapeutics Corporation (UTHR)vs › | $22.42B | 1.16 | 0.84 | 0.59 | 0.59 |
| Moderna, Inc. (MRNA)vs › | $23.70B | N/A | 0.18 | 0.14 | 0.14 |
| Incyte Corporation (INCY)vs › | $24.80B | 0.72 | 0.00 | 0.16 | 0.24 |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.07B | 33.99 | 33.99 | 32.78 | 16.88 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.18B | 1.43 | 4.21 | 4.21 | 2.20 |
| Labcorp Holdings Inc. (LH)vs › | $26.19B | 1.28 | 0.79 | 0.79 | 0.47 |
| Viatris Inc. (VTRS)vs › | $18.98B | N/A | 0.02 | 1.20 | 0.80 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.65B | N/A | 0.07 | 1.03 | 0.84 |
PEG Ratio
1.03
P/E Ratio
29.0
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2026-03-31 | 1.03 |
| 2025-03-31 | 0.58 |
| 2024-03-31 | 0.22 |
| 2020-03-31 | 0.86 |
| 2019-03-31 | 7.14 |
| 2018-03-31 | 0.17 |
| 2015-03-31 | 9.73 |
| 2013-03-31 | 0.85 |
| 2012-03-31 | 0.08 |
| 2010-03-31 | 0.97 |
| 2009-03-31 | 0.23 |
| 2007-03-31 | 0.94 |
| 2004-03-31 | 0.98 |
| 2003-03-31 | 0.33 |
| 2002-03-31 | 0.01 |
| 1999-03-31 | 0.70 |
| 1997-03-31 | 0.11 |
